Oxford BioMedica plc Share Price London S.E.
Equities
GB0006648157_GB
GB0006648157
Biotechnology & Medical Research
Sales 2023 | 89.54M 112M 9.38B | Sales 2024 * | 129M 163M 13.57B | Capitalization | 318M 399M 33.27B |
---|---|---|---|---|---|
Net income 2023 | -157M -197M -16.45B | Net income 2024 * | -36M -45.19M -3.77B | EV / Sales 2023 | 2.38 x |
Net cash position 2023 * | 49.23M 61.8M 5.16B | Net cash position 2024 * | 15.86M 19.91M 1.66B | EV / Sales 2024 * | 2.33 x |
P/E ratio 2023 |
-1.35
x | P/E ratio 2024 * |
-8.88
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 80.81% |
Latest transcript on Oxford BioMedica plc
Managers | Title | Age | Since |
---|---|---|---|
Frank Mathias
CEO | Chief Executive Officer | 62 | 27/23/27 |
Stuart Paynter
DFI | Director of Finance/CFO | 52 | 29/17/29 |
Chairman | 68 | 24/20/24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leone Patterson
BRD | Director/Board Member | 61 | 01/23/01 |
Chairman | 68 | 24/20/24 | |
Stuart Henderson
BRD | Director/Board Member | 66 | 01/16/01 |
1st Jan change | Capi. | |
---|---|---|
+5.66% | 111B | |
+11.23% | 105B | |
-0.38% | 21.93B | |
-12.15% | 22.34B | |
-7.66% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |